|
OMIM |
Link |
Information gain |
01 |
|
ALPS
|
[NCBI]
|
0.00839562
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.00425713
|
|
|
XLP1
|
[NCBI]
|
0.00289011
|
|
|
SH2D1A
|
[NCBI]
|
0.00256516
|
|
|
TNFRSF6
|
[NCBI]
|
0.000787251
|
|
|
CVID
|
[NCBI]
|
0.000344073
|
|
|
TNFSF6
|
[NCBI]
|
0.000331049
|
|
|
ALPS2A
|
[NCBI]
|
0.000292703
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.00026061
|
|
|
SLAMF1
|
[NCBI]
|
0.000253892
|
|
|
CD244
|
[NCBI]
|
0.000246939
|
|
|
ALK
|
[NCBI]
|
0.000172372
|
|
|
CASP10
|
[NCBI]
|
0.000162444
|
|
|
WAS
|
[NCBI]
|
0.000154719
|
|
|
IPEX
|
[NCBI]
|
0.000153796
|
|
|
CF
|
[NCBI]
|
0.000130227
|
|
|
LIP
|
[NCBI]
|
0.000120216
|
|
|
PRF1
|
[NCBI]
|
0.000115436
|
|
|
XLP2
|
[NCBI]
|
9.74931e-05
|
|
|
FOXP3
|
[NCBI]
|
9.20541e-05
|
|
|
LAT
|
[NCBI]
|
8.21331e-05
|
|
|
CHS
|
[NCBI]
|
7.99366e-05
|
|
|
BL
|
[NCBI]
|
7.55479e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
7.506e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
7.03133e-05
|
|
|
MTCP1
|
[NCBI]
|
6.78549e-05
|
|
|
SLAMF7
|
[NCBI]
|
6.78549e-05
|
|
|
human herpesvirus type 6, integrated
|
[NCBI]
|
6.66174e-05
|
|
|
interleukin 2 receptor, alpha, deficiency of
|
[NCBI]
|
6.66174e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
6.66174e-05
|
|
|
IS
|
[NCBI]
|
6.66174e-05
|
|
|
RA
|
[NCBI]
|
6.62449e-05
|
|
|
persistent polyclonal b-cell lymphocytosis
|
[NCBI]
|
6.11486e-05
|
|
|
BCL6
|
[NCBI]
|
6.11033e-05
|
|
|
FYN
|
[NCBI]
|
5.40849e-05
|
|
|
IGSF1
|
[NCBI]
|
5.40849e-05
|
|
|
CD48
|
[NCBI]
|
5.40849e-05
|
|
|
early lymphoid activation gene
|
[NCBI]
|
5.40849e-05
|
|
|
SLE
|
[NCBI]
|
5.13723e-05
|
|
|
SPHK2
|
[NCBI]
|
4.88942e-05
|
|
|
BCL5
|
[NCBI]
|
4.88942e-05
|
|
|
SLAMF6
|
[NCBI]
|
4.88942e-05
|
|
|
RBL1
|
[NCBI]
|
4.88942e-05
|
|
|
ADA
|
[NCBI]
|
4.58521e-05
|
|
|
GSK3A
|
[NCBI]
|
4.55271e-05
|
|
|
PRAME
|
[NCBI]
|
4.55271e-05
|
|
|
IL12RB2
|
[NCBI]
|
4.55271e-05
|
|
|
HMGA1
|
[NCBI]
|
4.55271e-05
|
|
|
TMPO
|
[NCBI]
|
4.55271e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
4.51513e-05
|
|
|
CCND3
|
[NCBI]
|
4.30261e-05
|
|
|
CEBPE
|
[NCBI]
|
4.10353e-05
|
|
|
BIRC4
|
[NCBI]
|
4.10353e-05
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
3.96095e-05
|
|
|
INPP5D
|
[NCBI]
|
3.79673e-05
|
|
|
CES1
|
[NCBI]
|
3.79673e-05
|
|
|
GSK3B
|
[NCBI]
|
3.56361e-05
|
|
|
HMBS
|
[NCBI]
|
3.51541e-05
|
|
|
E2F1
|
[NCBI]
|
3.29384e-05
|
|
|
STAT5B
|
[NCBI]
|
3.29384e-05
|
|
|
TCL1A
|
[NCBI]
|
3.21837e-05
|
|
|
CASP8
|
[NCBI]
|
3.08314e-05
|
|
|
NRAS
|
[NCBI]
|
2.96461e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.86271e-05
|
|
|
TCRA
|
[NCBI]
|
2.81052e-05
|
|
|
TNFSF8
|
[NCBI]
|
2.81052e-05
|
|
|
TNFSF13B
|
[NCBI]
|
2.81052e-05
|
|
|
ETV6
|
[NCBI]
|
2.56174e-05
|
|
|
CTLA4
|
[NCBI]
|
2.49155e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
2.48041e-05
|
|
|
IL3
|
[NCBI]
|
2.45834e-05
|
|
|
BCR
|
[NCBI]
|
2.41581e-05
|
|
|
VEGF
|
[NCBI]
|
2.36376e-05
|
|
|
ERBB2
|
[NCBI]
|
2.33624e-05
|
|
|
CML
|
[NCBI]
|
2.32316e-05
|
|
|
LAM
|
[NCBI]
|
2.29825e-05
|
|
|
TPMT
|
[NCBI]
|
2.00417e-05
|
|
|
CSF3
|
[NCBI]
|
2.00417e-05
|
|
|
STAT5A
|
[NCBI]
|
1.80894e-05
|
|
|
IL10
|
[NCBI]
|
1.71834e-05
|
|
|
NGFR
|
[NCBI]
|
1.56164e-05
|
|
|
ACP5
|
[NCBI]
|
1.53834e-05
|
|
|
NPM1
|
[NCBI]
|
1.39007e-05
|
|
|
JAK2
|
[NCBI]
|
1.36158e-05
|
|
|
TNF
|
[NCBI]
|
1.23758e-05
|
|
|
CCND1
|
[NCBI]
|
1.1866e-05
|
|
|
JMML
|
[NCBI]
|
1.16731e-05
|
|
|
APS1
|
[NCBI]
|
1.01508e-05
|
|
|
OSM
|
[NCBI]
|
8.9532e-06
|
|
|
PCNA
|
[NCBI]
|
8.23242e-06
|
|
|
IP
|
[NCBI]
|
6.97221e-06
|
|
|
FGFR3
|
[NCBI]
|
6.37597e-06
|
|
|
NGFB
|
[NCBI]
|
5.88995e-06
|
|
|
PD
|
[NCBI]
|
5.66642e-06
|
|
|
MPO
|
[NCBI]
|
5.64688e-06
|
|
|
IL2
|
[NCBI]
|
4.61117e-06
|
|
|
AR
|
[NCBI]
|
2.85673e-06
|
|
|
FRAP1
|
[NCBI]
|
2.7956e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.62092e-06
|
|
|
SPP1
|
[NCBI]
|
7.07203e-07
|
|
|
EPO
|
[NCBI]
|
5.59307e-07
|
|
|
MUC1
|
[NCBI]
|
1.97343e-07
|
|